FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043630462> ?p ?o ?g. }

• W2043630462 abstract "Benzodiazepines are the mainstay of treatment for mild-to-moderate alcohol withdrawal in outpatient settings, but they can interact with alcohol, cause motor incoordination, or be abused. This study compared the therapeutic responses of the benzodiazepine lorazepam and the anticonvulsant carbamazepine for the outpatient treatment of acute alcohol withdrawal in terms of patients' previous detoxification histories, and compared the effects of these 2 medications on drinking behaviors in the immediate postdetoxification period.This was a randomized double-blind trial comparing patient responses to carbamazepine and lorazepam across 2 levels of detoxification histories (0-1 or >or=2 previous medicated detoxifications).A university medical center substance abuse clinic in Charleston, SC.One hundred thirty-six patients in moderate alcohol withdrawal were randomized. Major exclusions were significant hepatic or hematologic abnormalities and use of medications that could alter withdrawal symptoms.Patients received 600-800 mg of carbamazepine or 6-8 mg of lorazepam in divided doses on day 1 tapering to 200 mg of carbamazepine or 2 mg of lorazepam.The Clinical Institute Withdrawal Assessment for Alcohol-Revised was used to assess alcohol withdrawal symptoms on days 1 through 5 and postmedication at days 7 and 12. Daily drinking was measured by patient report using a daily drinking log and a breath alcohol level with each visit. Side effects were recorded daily.Carbamazepine and lorazepam were equally effective at decreasing the symptoms of alcohol withdrawal. In the post-treatment period, 89 patients drank on at least 1 day; on average, carbamazepine patients drank less than 1 drink per drinking day and lorazepam patients drank almost 3 drinks per drinking day (P =.003). Among those with multiple past detoxifications, the carbamazepine group drank less than 1 drink per day on average and the lorazepam group drank about 5 drinks per day on average (P =.033). Lorazepam-treated patients had a significant rebound of alcohol withdrawal symptoms post-treatment (P =.007) and the risk of having a first drink was 3 times greater (P =.04) than for carbamazepine-treated patients. Twenty percent of lorazepam-treated patients had dizziness, motor incoordination, or ataxia and did not recognize their impairment. Twenty percent of carbamazepine-treated patients reported pruritus but no rash.Carbamazepine and lorazepam were both effective in decreasing the symptoms of alcohol withdrawal in relatively healthy, middle-aged outpatients. Carbamazepine, however, was superior to lorazepam in preventing rebound withdrawal symptoms and reducing post-treatment drinking, especially for those with a history of multiple treated withdrawals." @default.
• W2043630462 created "2016-06-24" @default.
• W2043630462 creator A5028686582 @default.
• W2043630462 creator A5032395562 @default.
• W2043630462 creator A5057442519 @default.
• W2043630462 creator A5063146551 @default.
• W2043630462 creator A5071415527 @default.
• W2043630462 creator A5075420771 @default.
• W2043630462 date "2002-05-01" @default.
• W2043630462 modified "2023-10-04" @default.
• W2043630462 title "The Effects of Carbamazepine and Lorazepam on Single versus Multiple Previous Alcohol Withdrawals in an Outpatient Randomized Trial" @default.
• W2043630462 cites W106360673 @default.
• W2043630462 cites W1518214111 @default.
• W2043630462 cites W1611330866 @default.
• W2043630462 cites W1847168837 @default.
• W2043630462 cites W190287805 @default.
• W2043630462 cites W1922131974 @default.
• W2043630462 cites W1970099077 @default.
• W2043630462 cites W1974023988 @default.
• W2043630462 cites W1976153901 @default.
• W2043630462 cites W1981871258 @default.
• W2043630462 cites W1984112365 @default.
• W2043630462 cites W1995357866 @default.
• W2043630462 cites W1997007504 @default.
• W2043630462 cites W2003739359 @default.
• W2043630462 cites W2007088934 @default.
• W2043630462 cites W2008854521 @default.
• W2043630462 cites W2019873672 @default.
• W2043630462 cites W2019884656 @default.
• W2043630462 cites W2024833487 @default.
• W2043630462 cites W2026013481 @default.
• W2043630462 cites W2026425372 @default.
• W2043630462 cites W2027632650 @default.
• W2043630462 cites W2028722367 @default.
• W2043630462 cites W2029561151 @default.
• W2043630462 cites W2037364977 @default.
• W2043630462 cites W2040461594 @default.
• W2043630462 cites W2042931973 @default.
• W2043630462 cites W2058161128 @default.
• W2043630462 cites W2061935843 @default.
• W2043630462 cites W2072283508 @default.
• W2043630462 cites W2076117152 @default.
• W2043630462 cites W2078994454 @default.
• W2043630462 cites W2085628148 @default.
• W2043630462 cites W2086961032 @default.
• W2043630462 cites W2089701189 @default.
• W2043630462 cites W2090520944 @default.
• W2043630462 cites W2094346333 @default.
• W2043630462 cites W2111868520 @default.
• W2043630462 cites W2113884577 @default.
• W2043630462 cites W2122195069 @default.
• W2043630462 cites W2143004261 @default.
• W2043630462 cites W2145032004 @default.
• W2043630462 cites W2148080316 @default.
• W2043630462 cites W2158666090 @default.
• W2043630462 cites W2167311298 @default.
• W2043630462 cites W2172232211 @default.
• W2043630462 cites W2202718451 @default.
• W2043630462 cites W2284599679 @default.
• W2043630462 cites W3377490 @default.
• W2043630462 cites W4242430308 @default.
• W2043630462 cites W4246574343 @default.
• W2043630462 cites W4299797587 @default.
• W2043630462 doi "https://doi.org/10.1046/j.1525-1497.2002.10201.x" @default.
• W2043630462 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1495040" @default.
• W2043630462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12047731" @default.
• W2043630462 hasPublicationYear "2002" @default.
• W2043630462 type Work @default.
• W2043630462 sameAs 2043630462 @default.
• W2043630462 citedByCount "69" @default.
• W2043630462 countsByYear W20436304622012 @default.
• W2043630462 countsByYear W20436304622013 @default.
• W2043630462 countsByYear W20436304622015 @default.
• W2043630462 countsByYear W20436304622016 @default.
• W2043630462 countsByYear W20436304622017 @default.
• W2043630462 countsByYear W20436304622018 @default.
• W2043630462 countsByYear W20436304622019 @default.
• W2043630462 countsByYear W20436304622020 @default.
• W2043630462 countsByYear W20436304622021 @default.
• W2043630462 countsByYear W20436304622022 @default.
• W2043630462 countsByYear W20436304622023 @default.
• W2043630462 crossrefType "journal-article" @default.
• W2043630462 hasAuthorship W2043630462A5028686582 @default.
• W2043630462 hasAuthorship W2043630462A5032395562 @default.
• W2043630462 hasAuthorship W2043630462A5057442519 @default.
• W2043630462 hasAuthorship W2043630462A5063146551 @default.
• W2043630462 hasAuthorship W2043630462A5071415527 @default.
• W2043630462 hasAuthorship W2043630462A5075420771 @default.
• W2043630462 hasBestOaLocation W20436304622 @default.
• W2043630462 hasConcept C118552586 @default.
• W2043630462 hasConcept C126322002 @default.
• W2043630462 hasConcept C142724271 @default.
• W2043630462 hasConcept C168563851 @default.
• W2043630462 hasConcept C170493617 @default.
• W2043630462 hasConcept C185592680 @default.
• W2043630462 hasConcept C204787440 @default.
• W2043630462 hasConcept C2775858608 @default.
• W2043630462 hasConcept C2778173252 @default.
• W2043630462 hasConcept C2778186239 @default.
• W2043630462 hasConcept C2779253243 @default.

• next